| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/30/2023 | 189.86% | RBC Capital | $7 → $6 | Maintains | Outperform |
| 10/20/2023 | 44.93% | Wells Fargo | $5 → $3 | Maintains | Equal-Weight |
| 10/11/2023 | 69.08% | Truist Securities | $5 → $3.5 | Maintains | Hold |
| 08/07/2023 | 214.01% | Oppenheimer | → $6.5 | Reiterates | Outperform → Outperform |
| 06/20/2023 | 141.55% | Truist Securities | $4.5 → $5 | Maintains | Hold |
| 05/03/2023 | 238.16% | Citigroup | $9 → $7 | Maintains | Buy |
| 05/03/2023 | 238.16% | RBC Capital | $11 → $7 | Maintains | Outperform |
| 05/03/2023 | 141.55% | Wells Fargo | $8 → $5 | Maintains | Equal-Weight |
| 05/03/2023 | 257.49% | Credit Suisse | $8.5 → $7.4 | Maintains | Neutral |
| 05/02/2023 | 214.01% | Oppenheimer | → $6.5 | Reiterates | → Outperform |
| 02/17/2023 | 310.63% | Credit Suisse | $3.3 → $8.5 | Maintains | Neutral |
| 01/19/2023 | 165.7% | Oppenheimer | $5 → $5.5 | Maintains | Outperform |
| 01/03/2023 | 117.39% | Wells Fargo | $3 → $4.5 | Maintains | Equal-Weight |
| 11/23/2022 | 59.42% | Credit Suisse | $4 → $3.3 | Maintains | Neutral |
| 08/01/2022 | 214.01% | Credit Suisse | $8 → $6.5 | Maintains | Neutral |
| 07/29/2022 | 189.86% | Oppenheimer | $16 → $6 | Maintains | Outperform |
| 06/17/2022 | 141.55% | Loop Capital | → $5 | Initiates Coverage On | → Hold |
| 06/15/2022 | 165.7% | B of A Securities | $7.5 → $5.5 | Downgrades | Buy → Neutral |
| 05/02/2022 | 310.63% | Wells Fargo | $12 → $8.5 | Maintains | Equal-Weight |
| 04/29/2022 | 576.33% | Citigroup | $18 → $14 | Maintains | Buy |
| 04/29/2022 | 817.87% | RBC Capital | $21 → $19 | Maintains | Outperform |
| 03/29/2022 | 479.71% | Wells Fargo | → $12 | Initiates Coverage On | → Equal-Weight |
| 12/13/2021 | 672.95% | B of A Securities | $14 → $16 | Upgrades | Underperform → Buy |
| 10/29/2021 | 600.48% | Credit Suisse | $12 → $14.5 | Maintains | Neutral |
| 09/24/2021 | 503.86% | UBS | → $12.5 | Initiates Coverage On | → Neutral |
| 08/03/2021 | 383.09% | Barclays | $6 → $10 | Maintains | Underweight |
| 07/30/2021 | 479.71% | Credit Suisse | $10 → $12 | Maintains | Neutral |
| 07/09/2021 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 06/10/2021 | 914.49% | RBC Capital | $12 → $21 | Upgrades | Sector Perform → Outperform |
| 05/05/2021 | 769.57% | Jefferies | $11 → $18 | Upgrades | Hold → Buy |
| 04/30/2021 | 383.09% | Credit Suisse | $4.1 → $10 | Upgrades | Underperform → Neutral |
| 02/19/2021 | 98.07% | Credit Suisse | $3.5 → $4.1 | Maintains | Underperform |
| 05/04/2020 | 238.16% | Oppenheimer | $8 → $7 | Maintains | Outperform |
| 02/20/2020 | 93.24% | B of A Securities | $3.5 → $4 | Maintains | Underperform |
| 02/20/2020 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 12/18/2019 | 69.08% | SunTrust Robinson Humphrey | $4 → $3.5 | Maintains | Hold |
| 10/31/2018 | 93.24% | Cantor Fitzgerald | $6 → $4 | Maintains | Neutral |
What is the target price for Community Health Sys (CYH)?
The latest price target for Community Health Sys (NYSE: CYH) was reported by RBC Capital on October 30, 2023. The analyst firm set a price target for $6.00 expecting CYH to rise to within 12 months (a possible 189.86% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Community Health Sys (CYH)?
The latest analyst rating for Community Health Sys (NYSE: CYH) was provided by RBC Capital, and Community Health Sys maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Community Health Sys (CYH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Health Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Health Sys was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.
Is the Analyst Rating Community Health Sys (CYH) correct?
While ratings are subjective and will change, the latest Community Health Sys (CYH) rating was a maintained with a price target of $7.00 to $6.00. The current price Community Health Sys (CYH) is trading at is $2.07, which is out of the analyst's predicted range.